Incyte | Der Umsatz



Sales Veränderung Datum
Acadia Pharmaceuticals USD 264.6M 20.28M 2025-06
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
Alnylam Pharmaceuticals USD 773.69M 179.5M 2025-06
Amgen USD 9.18B 1.03B 2025-06
Biogen USD 2.6B 170M 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Eli Lilly USD 15.56B 2.83B 2025-06
Exelixis USD 568.3M 12.9M 2025-06
Gilead Sciences USD 7.1B 430M 2025-06
Incyte USD 1.06B 10M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
MacroGenics USD 19.35M 91.35M 2024-12
Merck USD 15.81B 280M 2025-06
Moderna USD 142M 34M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Novartis USD 14.05B 821M 2025-06
Novartis USD 13.56B 386M 2024-12
Pfizer USD 14.7B 980M 2025-06
PTC Therapeutics USD 178.9M 11.1M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Sarepta Therapeutics USD 611.09M 163.81M 2025-06
Ultragenyx Pharmaceutical USD 166.5M 27.21M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06


Incyte Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.